Steward Partners Investment Advisory’s Akero Therapeutics AKRO Stock Holding History

Steward Partners Investment Advisory’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-136	Closed	-$6.46K	–	4309
2025 Q3	$6.46K	Buy	+136	New	+$6.59K	﹤0.01%	3570
2021 Q2	–	Sell	-125	Closed	-$3.63K	–	7076
2021 Q1	$3.63K	Buy	+125	New	+$3.78K	﹤0.01%	3087

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Steward Partners Investment Advisory's AKRO Position: Q4 2025 in Review

Steward Partners Investment Advisory sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 136 shares — an estimated $6.46K sold.

Steward Partners Investment Advisory first reported a position in AKRO in Q1 2021 and held it in 2 quarters. The position peaked at $6.46K in Q3 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

Steward Partners Investment Advisory reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
Steward Partners Investment Advisory sold 136 Akero Therapeutics shares in Q4 2025, an estimated $6.46K.
Steward Partners Investment Advisory first reported a position in Akero Therapeutics in Q1 2021 and held it in 2 quarters.
Steward Partners Investment Advisory's Akero Therapeutics position peaked at $6.46K in Q3 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2025, filed 12 Feb 2026.